<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Between 1968 and 1970, 226 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> were treated with <z:chebi fb="1" ids="35620">vasodilator</z:chebi> drugs </plain></SENT>
<SENT sid="1" pm="."><plain>In the subsequent three years (1971 to 1973) 202 patients were instead treated with <z:chebi fb="0" ids="52071">dextran</z:chebi> (Rheomacrodex) infusions. tin the latter period the <z:hpo ids='HP_0011420'>death</z:hpo>-rate was 35%, 19% less than during the preceding period of <z:chebi fb="1" ids="35620">vasodilator</z:chebi> treatment </plain></SENT>
<SENT sid="2" pm="."><plain>In the <z:chebi fb="0" ids="52071">dextran</z:chebi> group among patients over 65 years the <z:hpo ids='HP_0011420'>death</z:hpo>-rate was 42%, 21% less than in the <z:chebi fb="1" ids="35620">vasodilator</z:chebi> group of the same age </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="52071">Dextran</z:chebi> treatment caused complete disappearance of neurological signs in 25%, compared with 7.5% in the <z:chebi fb="1" ids="35620">vasodilator</z:chebi> group </plain></SENT>
<SENT sid="4" pm="."><plain>Dividing patients into those with <z:mpath ids='MPATH_458'>normal</z:mpath> blood pressure, <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> gave corresponding differences among the two groups </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:hpo ids='HP_0011420'>death</z:hpo>-rate during the period of <z:chebi fb="0" ids="52071">dextran</z:chebi> treatment was significantly less in <z:hpo ids='HP_0000001'>all</z:hpo> the sub-groups than in the <z:chebi fb="1" ids="35620">vasodilator</z:chebi> years </plain></SENT>
<SENT sid="6" pm="."><plain>The results of this retrospective study provide important pointers to the effectiveness of <z:chebi fb="0" ids="52071">dextran</z:chebi> infusion in the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
</text></document>